№ lp_1_2_29821
This document provides a resubmission to PBAC regarding prasugrel for the treatment of acute coronary syndrome.
Year: 2024
Region / City: Australia
Topic: Pharmaceutical Resubmission
Document Type: Early Re-entry Submission
Organization / Institution: Pharmaceutical Benefits Advisory Committee (PBAC)
Author: Generic Health Pty Ltd
Target Audience: Health professionals, regulatory bodies
Period of validity: March 2024 onwards
Approval Date: March 2024
Amendment Date: Not applicable
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.